The Department of Health today (August 11) endorses the proposal of GlaxoSmithKline Ltd, a licensed drug wholesaler, to recall one batch (batch no.: XPN161R) of its product, Coldrex+C Tablet 20's (registration no.: HK-50258) from consumers as the batch's dosage instruction in Chinese has an error.   Close